A-HPC collection: large volume or tailored procedure

Hematopoietic stem cells in peripheral blood are the most widely used source in Hematopoietic Progenitor Cell (HPC) transplantation in sequence with highdose (HD) myeloablative chemotherapy in Multiple Myeloma, Lymphoma Hodgkin and non Hodgkin, and, sometimes, in Acute Leukemia. The aim of Autologous-HPC (A-HPC) infusion is a rapid recovery of hematopoiesis, reduction in morbidity and improvement of overall survival...